A Phase 2a trial of OPK88002 to treat pruritus (itching) in Stage 5 CKD patients undergoing dialysis
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2017
At a glance
- Drugs OPK88002 (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors OPKO Health
- 08 Aug 2017 According to an Opko health media release, this study expected to begin in late 2017.
- 08 Aug 2017 According to an Opko health media release, Investigational New Drug application has been approved.
- 06 Jul 2017 New trial record